Inventor · disambiguated record
Wolfgang Pfleiderer
Also filed as: PFLEIDERER WOLFGANG · PFLEIDERER WOLFGANG E · PFLEIDERER WOLFGANG EUGEN
34 granted patents·7 pending applications·5,969 citations·filing 1974–2010
98Inventor score
Top patents by PatentIndex Score
41 records- 0199US5550111ADual action 2',5'-oligoadenylate antiviral derivatives and uses thereofUNIV TEMPLE·Filed 1994·Granted Aug 27, 1996·1.2k cites·31 claims
- 0298US5405939A2',5'-phosphorothioate oligoadenylates and their covalent conjugates with polylysineUNIV TEMPLE·Filed 1992·Granted Apr 11, 1995·1.3k cites·3 claims
- 0397US5188897AEncapsulated 2',5'-phosphorothioate oligoadenylatesUNIV TEMPLE·Filed 1990·Granted Feb 23, 1993·1.3k cites·27 claims
- 0496US5525711APteridine nucleotide analogs as fluorescent DNA probesUS HEALTH·Filed 1994·Granted Jun 11, 1996·1.5k cites·85 claims
- 0592US7501513B2Immunosuppressive effects of pteridine derivatives4 AZA BIOSCIENCE NV·Filed 2004·Granted Mar 10, 2009·28 cites·6 claims
- 0692US7276506B2Immunosuppressive effects of pteridine derivatives4 AZA BIOSCIENCE NV·Filed 2003·Granted Oct 2, 2007·32 cites·2 claims
- 0792US4924624A2,',5'-phosphorothioate oligoadenylates and plant antiviral uses thereofUNIV TEMPLE·Filed 1987·Granted May 15, 1990·61 cites·35 claims
- 0890US6946465B2Immunosuppressive effects of pteridine derivatives4 AZA BIOSCIENCE NV·Filed 2003·Granted Sep 20, 2005·42 cites·8 claims
- 0985US6844343B1N-substituted 4-aminopteridines, synthesis and use thereof as pharmaceutical agentVASOPHARM BIOTECH GMBH·Filed 2000·Granted Jan 18, 2005·37 cites·9 claims
- 1085US5643889ACholesterol conjugates of 2'5'-oligoadenylate derivatives and antiviral uses thereofUNIV TEMPLE·Filed 1994·Granted Jul 1, 1997·78 cites·16 claims
- 1177US7253176B1Immunosuppressive effects of 8-substituted xanthine derivativesLEUVEN K U RES & DEV·Filed 2000·Granted Aug 7, 2007·7 cites·4 claims
- 1275US5763599ANucleoside derivatives with photolabile protective groupsPFLEIDERER WOLFGANG·Filed 1995·Granted Jun 9, 1998·60 cites·30 claims
- 1372US5936077ASolid phase synthesis of oligonucleotidesHOECHST AG·Filed 1997·Granted Aug 10, 1999·26 cites·27 claims
- 1470US7759513B2Photolabile protective groups for improved processes to prepare oligonucleotide arraysNIGU CHEMIE GMBH·Filed 2004·Granted Jul 20, 2010·6 cites·46 claims
- 1569US5652358ASolid-phase synthesis of oligoribonucleotidesHOECHST AG·Filed 1994·Granted Jul 29, 1997·25 cites·31 claims
- 1668US5902810APteridine derivatives as no synthase inhibitorsHOECHST AG·Filed 1995·Granted May 11, 1999·27 cites·13 claims
- 1766US7662820B2Dipterinyl calcium pentahydrate (DCP) and therapeutic methods based thereonSANRX PHARMACEUTICALS INC·Filed 2007·Granted Feb 16, 2010·1 cites·3 claims
- 1865US5612468APteridine nucletide analogs as fluorescent DNA probesUS HEALTH·Filed 1995·Granted Mar 18, 1997·19 cites·20 claims
- 1964US2006189620A1Immunosuppressive effects of pteridine derivativesWAER MARK JOZEF A·Filed 2006·Application pending·0 cites
- 2063US8445734B2Photolabile protective groups for improved processes to prepare oligonucleotide arraysBUEHLER SIGRID·Filed 2010·Granted May 21, 2013·2 cites·19 claims
- 2161US6281201B1Base-modified derivatives of 2′,5′-oligoadenylate and antiviral uses thereofUNIV TEMPLE·Filed 1998·Granted Aug 28, 2001·13 cites·20 claims
- 2259US5863905A2',5'-phosphorothioate/phosphodiester oligoadenylates and anti-viral uses thereofUNIV TEMPLE·Filed 1997·Granted Jan 26, 1999·14 cites·48 claims
- 2359US4859768ADerivatives of 2', 5'-oligoadenylate and antiviral uses thereofUNIV TEMPLE·Filed 1988·Granted Aug 22, 1989·21 cites·16 claims
- 2458US6858612B1Use of tetrahydropteridine derivatives as no synthase inhibitorsVASOPHARM BIOTECH GMBH·Filed 1999·Granted Feb 22, 2005·15 cites·23 claims
- 2558US5556840A2',5'-phosphorothioate oligoadenylates as anitiviral agentsUNIV TEMPLE·Filed 1994·Granted Sep 17, 1996·9 cites·12 claims
- 2654US6750335B2Nucleoside derivatives with photolabile protective groupsNIGU CHEMIE GMBH·Filed 2002·Granted Jun 15, 2004·4 cites·13 claims
- 2754US5700785A3'-deoxy or 3'-O-substituted-2',5'-oligoadenylates as antiviral agentsUNIV TEMPLE·Filed 1994·Granted Dec 23, 1997·16 cites·37 claims
- 2854US3971792AProcess for the manufacture of 4-amino-3-aminomethylpiperidineCIBA GEIGY AG·Filed 1974·Granted Jul 27, 1976·3 cites·8 claims
- 2953US5866700ASolid-phase synthesis of oligoribonucleotidesHOECHST AG·Filed 1997·Granted Feb 2, 1999·9 cites·64 claims
- 3052US2007043000A1Immunosuppresive effects of pteridine derivativesWAER MARK J A·Filed 2004·Application pending·0 cites
- 3151US6716971B1Pteridine nucleotide analogsUS HEALTH·Filed 1999·Granted Apr 6, 2004·8 cites·30 claims
- 3251US2010105692A1Dipterinyl Calcium Pentahydrate (DCP) and Therapeutic Methods Based ThereonMOHENO PHILLIP·Filed 2009·Application pending·0 cites
- 3349US2004203036A1Multimer polynucleotide synthesisFiled 2004·Application pending·0 cites
- 3448US6153744ANucleoside derivatives with photolabile protective groupsWOLFGANG PFLEIDERER·Filed 1998·Granted Nov 28, 2000·10 cites·31 claims
- 3546US2008004285A1Pyrido(3,2-d)pyrimidines and pharmaceutical compositions useful for medical treatmentDE JONGHE STEVEN C A·Filed 2007·Application pending·0 cites
- 3644US5631362A5'-O-Dans EOC modified nucleosides and methods for preparing sameHOECHST AG·Filed 1995·Granted May 20, 1997·2 cites·4 claims
- 3744US2009264415A2Pyrido(3,2-d)pyrimidines and pharmaceutical compositions useful for medical treatmentDE JONGHE STEVEN·Filed 2008·Application pending·0 cites
- 3842US6362171B1Aminoaklanoyl-linked conjugates of 2′,5′-oligoadenylate and antiviral uses thereofUNIV TEMPLE·Filed 1998·Granted Mar 26, 2002·3 cites·23 claims
- 3936US6048975AProcess for the chemical synthesis of oligonucleotidesHOECHST AG·Filed 1997·Granted Apr 11, 2000·1 cites·41 claims
- 4036US2012251495A1Pterin based therapies for inflammatory conditionsMOHENO PHILLIP·Filed 2009·Application pending·0 cites
- 4133US5945524AProcess for the chemical synthesis of oligonucleotidesHOECHST AG·Filed 1995·Granted Aug 31, 1999·0 cites·42 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →